Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP.OB), today announced its quarterly financial results. As a result of several research programs and operations overhead, expenses are anticipated to increase over the next twelve months.One of the programs involves research into a novel drug used to treat mesothelioma called AmpTide(TM). AmpTide(TM) for Lung Cancer (Mesothelioma) Raptor Pharmaceuticals
Archive for the 'Raptor Pharmaceuticals Corporation' Category
Last update: April 01, 2019. 03:30:08 pm.